Regeneron Ventures

Venture capital firm

Recent changes

  1. Aug 11, 2026Invested in Infinimmune (Series A, $75M) MedCity News

Portfolio

1 total

Recent Investment Activity

1

Track record: led 1 and participated in 0 of 1 tracked venture round · 1 in the last 12 months · led 1 Series A

DateCompanyEventRoleAmountValuationInvestorsSource
Aug 11, 2026InfinimmuneSeries ALed$75M—Pulse story

Co-Investors

2

Similar Firms

overlapping sector, stage or region

Value Add Research

Latest Pulse

  1. Infinimmune Raises $75M for Human-Derived Antibody DrugsInfinimmune raised a $75 million Series A co-led by Regeneron Ventures and Playground Global to advance two atopic dermatitis antibody candidates built from its human-derived Anthrobody platform.→

Regeneron Ventures FAQ

What companies has Regeneron Ventures invested in?

Regeneron Ventures' portfolio includes Infinimmune.

Who does Regeneron Ventures co-invest with most?

In the rounds Value Add tracks, Regeneron Ventures most often invests alongside Civilization Ventures (1 shared deal), Pear VC (1 shared deal).

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction